cloprostenol veyx solution
modern veterinary therapeutics llc - cloprostenol (cloprostenol sodium) - solution - 0.25mg - cloprostenol (cloprostenol sodium) 0.25mg - cattle
epoprostenol drehm 500 microgram pdr+solv for soln for inf
drehm pharma gmbh - epoprostenol - pdr+solv for soln for inf - 500 microgram
epoprostenol drehm 1.5 milligram pdr+solv for soln for inf
drehm pharma gmbh - epoprostenol - pdr+solv for soln for inf - 1.5 milligram
epoprostenol myx epoprostenol (as sodium) 1.5 mg powder for injection vial with diluent vial
mayne pharma international pty ltd - epoprostenol sodium -
epoprostenol myx epoprostenol (as sodium) 500 microgram powder for injection vial with diluent vial
mayne pharma international pty ltd - epoprostenol sodium -
synchsure- cloprostenol sodium injection, solution
merial, inc. - cloprostenol sodium (unii: 886sav9675) (cloprostenol - unii:4208238832) - cloprostenol 250 ug in 1 ml - indications: for intramuscular use to induce luteolysis in beef and dairy cattle. the luteolytic action of synchsure can be utilized to manipulate the estrous cycle to better fit certain management practices, to terminate pregnancies resulting from mismatings, and to treat certain conditions associated with prolonged luteal function. contraindications: synchsure should not be administered to a pregnant animal whose calf is not to be aborted.
d-cloprostenol
fatro s.p.a. - d-cloprostenol - unknown - d-cloprostenol active 0.0 - active constituent
ovuprost injection
elanco australasia pty ltd - cloprostenol as the sodium salt - parenteral liquid/solution/suspension - cloprostenol as the sodium salt prostaglandin active 250.0 ug/ml - endocrine system - cow | horse mare (female) | bovine | female cattle | female horse - control of oestrus | cystic ovaries | early foetal death | extended dioestrus | induce abortion | induction of parturition | lactation anoestrus | pseudo-pregnancy | pyometra | sub oestrus | synchronisation of oestrus | induction of calving | prolonged weaning to mating | pseudo-cyesis | pseudo-pregnancy lactation | silent heat
veletri epoprostenol sodium injection powder lyophilized for solution
actelion pharmaceuticals us, inc. - epoprostenol sodium (unii: 4k04iq1of4) (epoprostenol - unii:dcr9z582x0) - epoprostenol sodium 1500000 ng in 10 ml
flolan epoprostenol sodium 1.5 mg powder for injection vial with diluent vial
glaxosmithkline australia pty ltd - epoprostenol sodium, quantity: 1.593 mg (equivalent: epoprostenol, qty 1.5 mg) - injection, powder for - excipient ingredients: sodium chloride; sodium hydroxide; mannitol; glycine - flolan is indicated for the long-term treatment, via continuous intravenous infusion, in who functional class iii or class iv patients with: idiopathic pulmonary arterial hypertension; familial pulmonary arterial hypertension; pulmonary arterial hypertension associated with the scleroderma spectrum of diseases.